Recurrent Breast Cancer Completed Phase 2 Trials for Gefitinib (DB00317)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

DBCOND0028640 (Recurrent Breast Cancer)Completed2 IdentifierTitlePurposeDrugs
NCT00024154Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast CancerTreatment
NCT00057941Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast CancerTreatment